The global Spatial Omics Market Growth Accelerated by Adoption of Spatial Omics Technology
Spatial omics pertains to the analysis of spatial relationships of biomolecules in tissues and cells. Spatial omics technology aids in the analysis and mapping of large biomolecules like DNA, RNA, and proteins at a high resolution and single-cell level. The technologies help understand disease mechanisms better by providing insights into intracellular processes. Spatial omics finds applications in drug discovery, diagnostics, and toxicological research.
The global Spatial Omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of spatial omics technology by biopharmaceutical and diagnostic companies is one of the major trends driving the growth of the market. Spatial analysis helps in drug target identification by analyzing the influence of the tumor microenvironment on disease progression and drug response at a cellular and subcellular level. Several biopharma companies are utilizing spatial omics approaches to gain better insights into disease pathophysiology and identify novel drug targets. Furthermore, spatial omics finds increasing applications in companion diagnostics by aiding in disease stratification, prognosis, and theranostics. Rapid technological advancements have widened the applications of spatial omics in various disease areas such as cancer, neurodegeneration, and infectious diseases.
Segment Analysis
The Global Spatial Omics Market is dominated by the spatial transcriptomics sub-segment. Spatial transcriptomics is widely used for spatial gene expression analysis as it allows the mapping of thousands of RNA transcripts simultaneously while retaining spatial information at a single-cell resolution. This has driven its widespread adoption over other spatial omics technologies in research applications.
Key Takeaways
The global spatial omics market is expected to witness high growth over the forecast period driven by technological advancements in spatial analysis techniques. Spatial profiling techniques are enabling deeper insights into complex tissue structures and disease pathogenesis. The global Spatial Omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030.
Regional analysis
North America currently dominates the global spatial omics market owing to extensive government funding for genomics and biomarker research, presence of major market players, and high adoption of advanced spatial profiling techniques among research laboratories in the US and Canada. Europe is also a major regional market supported by growing genomics research spending. However, the Asia Pacific region is expected to show highest growth over the forecast period with increasing investments in biotechnology and lifescience research from China, India, Japan and South Korea.
Key players
The key players operating in the spatial omics market are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode. 10x Genomics commands a strong position in the spatial transcriptomics sub-segment with its Chromium single-cell gene expression platform. Akoya Bioscience holds a leading share of the immunofluorescence-based spatial analysis technology segment with its CODEX platform.
Get more insights on this topic: http://marketerefforts.weebly.com/home/spatial-omics-market-is-estimated-to-witness-high-growth-owing-to-opportunity-to-advance-precision-medicine
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian